Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition-Reference-Cited by-同舟云学术

Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition

Published:2014-02-25 Issue:2 Volume:9 Page:e90202
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fernandez-Estevez Maria Angeles,Casarejos Maria Jose,López Sendon Jose,Garcia Caldentey Juan,Ruiz Carolina,Gomez Ana,Perucho Juan,de Yebenes Justo García,Mena Maria Angeles

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease;SE Andrew;Nat Genet,1993

2. Lessons from animal models of Huntington's disease;DC Rubinsztein;Trends Genet,2002

3. Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease;MS Hipp;J Cell Biol,2012

4. Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases;BA Bahr;Rejuvenation Res,2012

5. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS;UB Pandey;Nature,2007

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermal Fibroblast Cell Line from a Patient with the Huntington’s Disease as a Promising Model for Studying Disease Pathogenesis: Production and Characterization;Biochemistry (Moscow);2024-07

2. Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing pathways in neurodegenerative disorders and cancer;Ageing Research Reviews;2024-04

3. Role of Autophagy and Mitophagy in Neurodegenerative Disorders;CNS & Neurological Disorders - Drug Targets;2024-03

4. Regulation of the structural dynamics, aggregation, and pathogenicity of polyQ-expanded Huntingtin by osmolytes;Progress in Molecular Biology and Translational Science;2024

5. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease;Molecular Neurobiology;2023-09-12